Table 5.
Among patients identified as having an AOD use disorder in an outpatient or emergency department setting and initiated treatment (N=7,963), characteristics associated with AOD treatment engagement
| Characteristic associated with AOD treatment engagement | Identified in outpatient/ED setting (N=7963) N (%) or Median (IQR) | Unadjusted RR for engagement (95% CI) | Adjusted RR for engagement (95% CI) |
|---|---|---|---|
| Race/ethnicity | |||
| White | 5049 (63.4) | [Ref] | [Ref] |
| Asian | 257 (3.2) | 0.92 (0.79–1.09) | 0.97 (0.80–1.18) |
| African American | 668 (8.4) | 0.72 (0.63–0.82) | 0.76 (0.66–0.87) |
| Hispanic | 1394 (17.5) | 0.98 (0.89–1.07) | 0.98 (0.89–1.07) |
| Other/Unknown | 595 (7.5) | 1.11 (0.95–1.29) | 1.11 (0.98–1.27) |
| Age | 46.4 (17.7) | 0.99 (0.98–1.00) | -- |
| Sex | |||
| Male | 3660 (62.5) | [Ref] | [Ref] |
| Female | 2988 (37.5) | 1.02 (0.96–1.07) | 1.03 (0.97–1.09) |
| Index encounter setting | |||
| Outpatient | 4975 (62.5) | [Ref] | [Ref] |
| Emergency Department | 2669 (33.5) | 0.46 (0.42–0.51) | 0.47 (0.42–0.52) |
| Charlson/Deyo comorbidity index | |||
| 0 | 5310 (66.7) | [Ref] | [Ref] |
| 1 | 1433 (18.0) | 0.81 (0.73–0.89) | 0.85 (0.76–0.94) |
| 2+ | 1220 (15.3) | 0.58 (0.52–0.88) | 0.61 (0.53–0.71) |
| Diagnoses in the prior year | |||
| Tobacco dependence | 2061 (25.9) | 0.89 (0.81–0.98) | -- |
| Pregnancy/childbirth | 121 (1.5) | 0.92 (0.74–1.15) | -- |
| Injury/poisoning | 2848 (35.8) | 0.86 (0.83–0.90) | -- |
| Cirrhosis | 589 (7.4) | 0.93 (0.83–1.04) | -- |
| Hepatitis C | 228 (2.9) | 1.04 (0.91–1.20) | -- |
| Pancreatic disease | 199 (2.5) | 0.78 (0.72–0.85) | -- |
Abbreviations. IQR=interquartile range; RR = risk ratio; CI = confidence interval; AOD=alcohol or other drugs; -- indicates variables not included in adjusted analyses because they either were not significant in bivariate analyses (p-value ≥ 0.25) or forward selection modeling (p-value ≥ 0.25)